Equity Profile

GMED

Globus Medical, Inc.

Health CareHealth Care Equipment$10.9B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Globus Medical, Inc. (GMED) is a leading company in the health care equipment sector, specializing in innovative spinal and orthopedic implants....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

$1.12

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Globus Medical, Inc. (GMED) is a leading company in the health care equipment sector, specializing in innovative spinal and orthopedic implants. The company plays a crucial role in improving patient outcomes through advanced medical technologies, which is increasingly important as the demand for effective health care solutions grows.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

In Q1-2026, Globus Medical reported an EPS of $1.12, exceeding expectations by 22%. However, the stock fell by 4.65% the following day, indicating market skepticism despite the positive earnings surprise.

Management Promises & Guidance

Continued focus on innovation in spinal and orthopedic solutions.
Commitment to improving operational efficiency.
Plans to expand market presence in key regions.

Expectations

Wall Street Expectations

Overall, the market is cautiously optimistic about Globus Medical's upcoming earnings, especially given its strong track record of beating EPS estimates.

Bull Case

If the company continues its trend of exceeding EPS expectations, it could signal robust demand for its products and further solidify its market position.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, as seen in previous quarters.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.12

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand in the health care sector.

Gross Margin

N/A

Gross margin is important as it indicates how efficiently the company is producing its products relative to its sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be critical in determining market sentiment post-earnings.

How is revenue growth tracking in key markets?

Understanding revenue growth will provide insight into the company's market position and demand for its products.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of recent product innovations on sales growth, leading to a conservative EPS estimate.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, suggesting a potential for continued outperformance.

Options pricing indicates a significant expected move, which may reflect investor uncertainty rather than a lack of confidence in the company's fundamentals.

Key Risk

If revenue growth exceeds expectations, it could challenge the current conservative consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether the company's growth can continue in a competitive landscape, making these earnings critical.

Bull Confirmed If

An EPS of $1.15 or higher would confirm the bull case, indicating strong demand and effective cost management.

Bear Confirmed If

An EPS below $1.05 would confirm the bear case, suggesting potential issues with sales or margins.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±16.8% while GMED has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Globus Medical beats expectations, history suggests a potential stock increase of around 1.66%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement as investors reassess growth prospects.

Miss

Should the company miss its EPS target, history indicates a potential drop of around 1.33%, leading to increased concern about future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-CAGilbert CisnerosRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Insights into market share changes in key regions.
3Management's commentary on cost management strategies.
4Updates on competitive pressures in the health care equipment sector.
5Any guidance on future revenue expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Globus Medical, Inc. (GMED) is a leading company in the health care equipment sector, specializing in innovative spinal and orthopedic implants....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

$1.12

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

Management Promises & Guidance

Continued focus on innovation in spinal and orthopedic solutions.
Commitment to improving operational efficiency.
Plans to expand market presence in key regions.

Expectations

Wall Street Expectations

Overall, the market is cautiously optimistic about Globus Medical's upcoming earnings, especially given its strong track record of beating EPS estimates.

Bull Case

If the company continues its trend of exceeding EPS expectations, it could signal robust demand for its products and further solidify its market position.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, as seen in previous quarters.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.12

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand in the health care sector.

Gross Margin

N/A

Gross margin is important as it indicates how efficiently the company is producing its products relative to its sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be critical in determining market sentiment post-earnings.

How is revenue growth tracking in key markets?

Understanding revenue growth will provide insight into the company's market position and demand for its products.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of recent product innovations on sales growth, leading to a conservative EPS estimate.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, suggesting a potential for continued outperformance.

Options pricing indicates a significant expected move, which may reflect investor uncertainty rather than a lack of confidence in the company's fundamentals.

Key Risk

If revenue growth exceeds expectations, it could challenge the current conservative consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether the company's growth can continue in a competitive landscape, making these earnings critical.

Bull Confirmed If

An EPS of $1.15 or higher would confirm the bull case, indicating strong demand and effective cost management.

Bear Confirmed If

An EPS below $1.05 would confirm the bear case, suggesting potential issues with sales or margins.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±16.8% while GMED has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Globus Medical beats expectations, history suggests a potential stock increase of around 1.66%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement as investors reassess growth prospects.

Miss

Should the company miss its EPS target, history indicates a potential drop of around 1.33%, leading to increased concern about future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-CAGilbert CisnerosRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Insights into market share changes in key regions.
3Management's commentary on cost management strategies.
4Updates on competitive pressures in the health care equipment sector.
5Any guidance on future revenue expectations.